EndoCyclic Therapeutics is a biopharmaceutical company engaged in the development of the first non-hormone therapeutic for endometriosis. Endometriosis afflicts over 10% of women worldwide and is the #1 cause of infertility and disability among women in the reproductive years. Despite the prevalence of this painful disease, endometriosis is considered the most overlooked women’s health issue due to the lack of effective treatment options. EndoCyclic Therapeutics' team of world-class physicians, scientists, government officials and pharma/biotech professionals are actively working together to bring a solution to the millions of women suffering from endometriosis and awareness to this important women’s health issue. For more information, please visit www.endocyclictherapeutics.com.